Differential Functions of Splicing Factors in Mammary Transformation and Breast Cancer Metastasis-Reference-Cited by-同舟云学术

Differential Functions of Splicing Factors in Mammary Transformation and Breast Cancer Metastasis

Published:2019-11 Issue:9 Volume:29 Page:2672-2688.e7
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Park SungHee,Brugiolo Mattia,Akerman Martin,Das Shipra,Urbanski Laura,Geier Adam,Kesarwani Anil K.,Fan Martin,Leclair Nathan,Lin Kuan-Ting,Hu Leo,Hua Ian,George Joshy,Muthuswamy Senthil K.,Krainer Adrian R.,Anczuków Olga^ORCID

Funder

National Cancer Institute

NCI

National Institute of General Medical Sciences

Susan G. Komen Foundation for the Cure

Terri Brodeur Breast Cancer Foundation

JAX

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference110 articles.

1. The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation;Anczuków;Nat. Struct. Mol. Biol.,2012

2. SRSF1-Regulated Alternative Splicing in Breast Cancer;Anczuków;Mol. Cell,2015

3. Mechanism of Nonsense-Mediated mRNA Decay Stimulation by Splicing Factor SRSF1;Aznarez;Cell Rep.,2018

4. The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis at the plasma membrane;Baskin;Nat. Cell Biol.,2016

5. The GNAS Locus: Quintessential Complex Gene Encoding Gsalpha, XLalphas, and other Imprinted Transcripts;Bastepe;Curr. Genomics,2007

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico RNA isoform screening to identify potential cancer driver exons with therapeutic applications;Nature Communications;2024-08-15

2. PRPF40A induces inclusion of exons in GC-rich regions important for human myeloid cell differentiation;Nucleic Acids Research;2024-06-29

3. Molecular mechanisms of non-genetic aberrant peptide production in cancer;Oncogene;2024-05-27

4. Assessing the Impact of Novel BRCA1 Exon 11 Variants on Pre-mRNA Splicing;Cells;2024-05-11

5. In silico identification of a novel Cdc2‐like kinase 2 (CLK2) inhibitor in triple negative breast cancer;Protein Science;2024-05-09